Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers. (2022)

First Author: Alblihy A
Attributed to:  Identifying a Wnt pathway inhibitor for stem cell maintenance in IBD funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41698-022-00298-0

PubMed Identifier: 35853939

Publication URI: http://europepmc.org/abstract/MED/35853939

Type: Journal Article/Review

Volume: 6

Parent Publication: NPJ precision oncology

Issue: 1

ISSN: 2397-768X